Brief: Tetra Bio-Pharma Provides Update On Research Collaboration With The University Of Montreal Hospital Research Centre For Inhaled CBD
08/03/2022 11:32
March 8 (Reuters) - Tetra Bio Pharma Inc TBP.TO :
* TETRA BIO-PHARMA PROVIDES UPDATE ON RESEARCH COLLABORATION
WITH
THE UNIVERSITY OF MONTREAL HOSPITAL RESEARCH CENTRE FOR INHALED
CBD
* TETRA BIO - HEALTH CANADA APPROVED AMENDMENT OF PHASE I
STUDY TO
ASSESS EFFECT OF LOW AND MODERATE DOSES OF INHALED CBD IN
HEALTHY CANNABINOID USERS
Source text for Eikon: ID:nCNWzDN18a
Further company coverage: TBP.TO
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding